Problem: A laboratory is conducting platelet aggregation tests on 2 samples: one from a patient on aspirin therapy and one from a healthy individual without any medication. Platelet-rich plasma from both samples is placed in a tube and light transmission is measured. Agonists, such as ADP and collagen, are added to each sample to induce platelet aggregation. When comparing the light transmission through these samples after the addition of platelet agonists, what is the expected observation? Group of answer choices In both samples, an equal amount of light will pass through regardless of treatment. In the normal sample, more light passes through due to effective platelet aggregation. In the aspirin-treated sample, less light passes through due to reduced platelet aggregation. Aspirin inhibits platelet aggregation, so more light passes through in the aspirin-treated sample.